Skip to Main Content
An official website of the United States government

Learn About the HIP Breast Cancer Screening Trial

Main Findings

Major analyses of the primary trial endpoints were conducted at the 5, 7, and 18 year intervals from randomization and found that screening reduced mortality that was largely seen in the participants over the age of 50.